drugset / Trial / NCT05705635

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

NCT05705635 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is a multicenter, randomized, controlled clinical study to evaluate the efficacy and safety of Docetaxel for Injection (Albumin-bound) and Taxotere in locally advanced or metastatic gastric adenocarcinoma or gastroesophageal junction adenocarcinoma.

Timeline

Start
2023-01-13
Primary completion
2023-05
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Docetaxel Small molecule — Intravenous